Sergio Traversa | executive |
Maged Shenouda | executive |
Cedric O'Gorman | executive |
Maddalena Delma Caiati | analyst |
Good afternoon, ladies and gentlemen, and welcome to the Relmada Therapeutics, Inc.
Third Quarter 2023 Earnings Conference Call. [Operator Instructions] Following the presentation, we will conduct a question-and-answer session.
[Operator Instructions] This call is being recorded on Wednesday, November 8, 2023. I would now like to turn the conference over to Tim McCarthy of LifeSci Advisors.